Clinical Trial Update: S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of phase 2 trial S9716 evaluating combination chemotherapy for Merkel cell carcinoma (neuroendocrine carcinoma of the skin).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Neuroendocrine Carcinoma of the Skin | Phase 2 | Status: COMPLETED